false
0001601548
0001601548
2026-05-07
2026-05-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of report (Date of earliest event
reported): May 7, 2026
V2X, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Indiana
(State or Other Jurisdiction of Incorporation)
| 001-36341 |
38-3924636 |
| (Commission |
(IRS
Employer |
| File Number) |
Identification No.) |
2100 Reston Parkway, Suite 300
Reston, VA 20191
(Address of Principal Executive Offices) (Zip Code)
(571) 481-2000
(Registrant's Telephone Number, Including
Area Code)
Securities Registered Under Section 12(b) of
the Act:
| Title of each class |
Trading
symbol(s) |
Name of each exchange on which registered |
| Common Stock, Par Value $0.01 Per Share |
VVX |
New York Stock Exchange |
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| ¨ | Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
On May 7, 2026, V2X, Inc.
(“V2X” or the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”), by
and among the Company, Vertex Aerospace Holdco LLC (the “Selling Shareholder”), and Morgan Stanley & Co. LLC, as
the sole underwriter (the “Underwriter”), relating to the public offering (the “Offering”) of 2,004,569 shares
of common stock, par value $0.01 per share (“common stock”) . The Underwriting Agreement contains customary representations,
warranties, covenants and indemnification obligations of the Company, the Selling Shareholder and the Underwriter, as well as termination
and other customary provisions. The Offering was made pursuant to the Company’s shelf registration statement on Form S-3 (File
No. 333-267223) that was declared effective under the Securities Act of 1933, as amended, by the Securities and Exchange Commission
on September 12, 2022, and a related prospectus supplement dated May 7, 2026 (the “Prospectus”).
The Offering closed on May 11,
2026. The Company did not sell any securities in the Offering and will not receive any proceeds from the sale of the shares offered by
the Selling Shareholder. Following the Offering, the Selling Shareholder will no longer own any shares of common stock. An entity affiliated
with the Selling Stockholder will, however, continue to beneficially own 375,420 shares, or approximately 1.2%, of the Company’s
outstanding common stock after giving effect to the Offering.
The foregoing description
of the Underwriting Agreement is qualified in its entirety by reference to the full text of the Underwriting Agreement. A copy of the
Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K.
The Underwriting Agreement
and the above descriptions have been included to provide investors and security holders with information regarding the terms of the Underwriting
Agreement. They are not intended to provide any other factual information about the Company or its subsidiaries or affiliates or equity
holders. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of that agreement
and as of specific dates, were solely for the benefit of the parties to the Underwriting Agreement, and may be subject to limitations
agreed upon by the parties, including being qualified by confidential disclosures made by each contracting party to the other as a way
of allocating contractual risk between them that differ from those applicable to investors. Moreover, the subject matter of the representations
and warranties is subject to more recent developments. Accordingly, investors should be aware that these representations, warranties and
covenants or any description thereof alone may not describe the actual state of affairs of the Company or its subsidiaries, affiliates,
businesses or equity holders as of the date they were made or at any other time.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit
No. |
|
Description |
| |
|
|
| 1.1 |
|
Underwriting Agreement, dated May 7, 2026, by and among V2X, Inc., Vertex Aerospace Holdco LLC and Morgan Stanley & Co. LLC, as underwriter |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
V2X, INC. |
| |
|
| Dated: May 11, 2026 |
By: |
/s/ Sarita B. Malakar |
| |
|
Sarita B. Malakar |
| |
|
Corporate Secretary |